Summary

Eligibility
for people ages 40 years and up (full criteria)
Location
at UCLA
Dates
study started
completion around
Principal Investigator
by Igor Barjaktarevic, MD, PhD (ucla)
Headshot of Igor Barjaktarevic
Igor Barjaktarevic

Description

Summary

This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk and improving quality of life, functional status, rescue medication use.

Details

The Multi-Center Clean Air Randomized Controlled Trial in COPD (Clean Air) is a multi-center, prospective, randomized, double-blind, sham-controlled trial that will enroll 770 former smokers with COPD over a 4-year period and follow participants at regular intervals for one year. The primary endpoint is respiratory specific quality of life. Secondary endpoints include rate of acute exacerbations, rescue medication use, quality of life, and cost-effectiveness.

Keywords

Chronic Obstructive Pulmonary Disease (COPD), air cleaner, indoor air quality, quality of life, rescue medication use, Obstructive Lung Diseases, Chronic Obstructive Pulmonary Disease

Eligibility

Locations

  • University of California, Los Angeles accepting new patients
    Los Angeles California 90095 United States
  • University of Iowa accepting new patients
    Iowa City Iowa 52242 United States

Lead Scientist at University of California Health

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
JHSPH Center for Clinical Trials
ID
NCT06376994
Phase
Phase 3 Chronic Obstructive Pulmonary Disease Research Study
Study Type
Interventional
Participants
Expecting 770 study participants
Last Updated